Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2010-03-03FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved a supplemental application to expand Claritin Chewable by adding grape and bubblegum flavored loratadine chewables, under B…
-
FDA approval · 2010-02-19FDA Approved: DESLORATADINE — Original Application (Bionpharma Inc.)
FDA approved the original ANDA for desloratadine from Bionpharma Inc., a generic antihistamine. The approval is for the treatment of allergi…
-
CLINICAL_TRIALS trial_result · 2010-02-10Clinical Trial Update: Fractional Exhaled Nitric Oxide (FeNO) Result Prediction Factors in Children With Allergic Diseases
A completed clinical trial in children with allergic diseases investigates factors that predict fractional exhaled nitric oxide (FeNO) resul…
-
CLINICAL_TRIALS trial_result · 2010-02-04Clinical Trial Update: Safety and Pharmacokinetics of Patanase in Pediatric Patients 2 to < 6 Years of Age [Phase 2]
Phase 2 safety and pharmacokinetics study of Patanase (olopatadine nasal spray) in children aged 2 to less than 6 with allergic rhinitis; re…
-
FDA approval · 2010-02-02FDA Approved: CHILDRENS ALLERGY RELIEF — Original Application (C.D.M.A., Inc.)
FDA approved the original ANDA for CHILDRENS ALLERGY RELIEF containing cetirizine hydrochloride by C.D.M.A., Inc., establishing a generic pe…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-02-02Clinical Trial Update: Evaluation of the Sensory Attributes of Olopatadine 0.6% and Azelastine 137mcg Nasal Sprays in Patients w/Allergic Rhinitis [Phase 4]
Phase 4 trial assessing sensory attributes of olopatadine 0.6% and azelastine 137 mcg nasal sprays in patients with allergic rhinitis; resul…
-
FDA approval · 2010-01-25FDA Approved: CLARITIN-D 12 HOUR — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for CLARITIN-D 12 HOUR (loratadine and pseudoephedrine sulfate) from Bayer HealthCare LLC.
-
FDA approval · 2010-01-25FDA Approved: CLARITIN-D 24 HOUR — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for CLARITIN-D 24 HOUR (loratadine and pseudoephedrine sulfate) from Bayer HealthCare LLC. The actio…
-
FDA approval · 2010-01-21FDA Approved: CETIRIZINE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal Pharmaceuticals' original application for cetirizine hydrochloride, granting a generic version of cetirizine for all…
-
CLINICAL_TRIALS trial_result · 2010-01-15Clinical Trial Update: Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS [Phase 4]
Phase 4 trial comparing patient experience and preference between fluticasone furoate nasal spray and fluticasone propionate nasal spray for…
-
EMA withdrawal · 2009-12-31EMA Withdrawn: Allex (desloratadine) — Schering-Plough Europe
Desloratadine product Allex (Schering-Plough Europe) has been withdrawn from the market.
-
FDA approval · 2009-12-30FDA Approved: CLARINEX-D 12 HOUR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for CLARINEX-D 12 HOUR, a combination of desloratadine and pseudoephedrine sulfate, manufactured by …
-
CLINICAL_TRIALS trial_result · 2009-12-23Clinical Trial Update: A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis [Phase 4]
A Phase 4 clinical trial evaluating fluticasone furoate nasal spray for perennial allergic rhinitis completed, with study results posted in …
-
CLINICAL_TRIALS trial_result · 2009-12-09Clinical Trial Update: Effect of a 10,000 EU Dose of Endotoxin in Allergic and Mildly Asthmatic Adults [Phase 1]
Clinical trial results from a Phase 1 study of a 10,000 EU dose of endotoxin in adults with allergic rhinitis (perennial and seasonal) and m…
-
CLINICAL_TRIALS trial_result · 2009-11-25Clinical Trial Update: A Pilot Study In Adults And Adolescents With Irritant (Non-Allergic) Rhinitis [Phase 2]
A Phase 2 pilot study in adults and adolescents with irritant non-allergic rhinitis has completed, with results posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-11-19Clinical Trial Update: Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05583) [Phase 3]
Phase 3 clinical trial update for Nasonex in relieving nasal congestion in seasonal allergic rhinitis; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2009-11-13Clinical Trial Update: Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05529) [Phase 3]
This Phase 3 trial evaluated Nasonex (mometasone furoate nasal spray) for relief of nasal congestion in seasonal allergic rhinitis; results …
-
FDA approval · 2009-11-12FDA Approved: CETIRIZINE HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved cetirizine hydrochloride under an original application for use as a generic antihistamine indicated for allergic rhinitis and u…
-
CLINICAL_TRIALS trial_result · 2009-10-14Clinical Trial Update: Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months [Phase 3]
Phase 3 safety study of levocetirizine dihydrochloride oral liquid in children aged 6 to 11 months has completed, with results posted in 200…
-
FDA approval · 2009-10-07FDA Approved: CETIRIZINE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved a generic cetirizine hydrochloride product under an Original Abbreviated New Drug Application by Amneal Pharmaceuticals LLC.
-
FDA approval · 2009-10-07FDA Approved: CETIRIZINE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals' cetirizine hydrochloride as an Original Application (ANDA090765), establishing a generic cetirizine pro…
-
CLINICAL_TRIALS trial_result · 2009-10-02Clinical Trial Update: Study to Evaluate the Safety and Tolerability of a Nasal Spray in Patients With Chronic Allergic or Nonallergic Rhinitis [Phase 3]
Phase 3 clinical trial evaluating the safety and tolerability of a nasal spray for chronic allergic rhinitis and nonallergic rhinitis; the s…
-
CLINICAL_TRIALS trial_result · 2009-09-04Clinical Trial Update: Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin [Phase 3]
A Phase 3 safety trial of levocetirizine dihydrochloride oral solution in children aged 1 to under 6 with allergic rhinitis or chronic urtic…
-
FDA approval · 2009-08-31FDA Approved: GOOD NEIGHBOR PHARMACY CHILDRENS LORATADINE — Supplemental Application (AmerisourceBergen)
The FDA approved a supplemental application for Good Neighbor Pharmacy Children's Loratadine (loratadine) submitted by AmerisourceBergen.
-
FDA approval · 2009-08-26FDA Approved: ALLERGY RELIEF — Original Application (Prodose, Inc)
FDA approved an original application for ALLERGY RELIEF containing cetirizine hydrochloride, marketed by Prodose, Inc.